Involvement of cysteine proteases in bFGF-Induced angiogenesis in guinea pig and rat cornea

被引：15

作者：

Tamada, Y ^{[1
]}

Fukiage, C ^{[1
]}

Boyle, DL ^{[1
]}

Azuma, M ^{[1
]}

Shearer, TR ^{[1
]}

机构：

[1] Senju Pharmaceut Co Ltd, Res Labs, Nishi Ku, Kobe, Hyogo 65122, Japan

来源：

JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS | 2000年 / 16卷 / 03期

关键词：

D O I：

10.1089/jop.2000.16.271

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

Overexpression and activation of matrix metalloprotease (MMP) have been implicated in angiogenesis. However, the involvement of cysteine proteases, such as calpains (EC 34.22.17), is obscure. Thus, the purpose of this experiment was to study the involvement of cysteine proteases in angiogenesis induced by basic fibroblast growth factor (bFGF) in guinea pig and rat corneas using cysteine protease inhibitors. Sustained-release polymers containing bFGF were implanted into guinea pig and rat corneas to induce angiogenesis. For treatment of corneal angiogenesis, polymers containing cysteine protease inhibitors, leupeptin or SJA6017, were also implanted into corneas. Using the slit lamp, the corneas were observed for nine days after polymer implantation. Soluble proteins and albumin levels were used as markers of corneal injury by angiogenesis. bFGF induced angiogenesis in guinea pig and rat corneas. In guinea pig cornea, wet weight, the amount of soluble protein and albumin was highest at four days after bFGF-containing pellet implantation. In rat cornea, the amount of soluble protein and albumin was highest at six days, and wet weight increased within four days. One hundred nmole of leupeptin showed a tendency to reduce bFGF-induced angiogenesis in guinea pig cornea, and 10 nmole of SJA6017 was effective in reducing bFGF-induced angiogenesis in rat cornea, although SJA6017 showed a stronger effect than leupeptin. Ten nmole of SJA6017 significantly reduced the number of new blood vessels. These data suggested involvement of cysteine proteases in angiogenesis in guinea pig and rat cornea.

引用

页码：271 / 283

页数：13

共 27 条

[1]

Amano S, 1998, INVEST OPHTH VIS SCI, V39, P18

[2]

BOUCK N, 1990, CANCER CELL-MON REV, V2, P179

[3] PROLONGED ACTIVATION OF JUN AND COLLAGENASE GENES BY TUMOR NECROSIS FACTOR-ALPHA [J].

BRENNER, DA ;

OHARA, M ;

ANGEL, P ;

CHOJKIER, M ;

KARIN, M .

NATURE, 1989, 337 (6208) :661-663

[4] FOS AND JUN - THE AP-1 CONNECTION [J].

CURRAN, T ;

FRANZA, BR .

CELL, 1988, 55 (03) :395-397

[5] TUMOR ANGIOGENESIS [J].

FOLKMAN, J .

ADVANCES IN CANCER RESEARCH, 1985, 43 :175-203

[6] DEFINITION OF 2 ANGIOGENIC PATHWAYS BY DISTINCT ALPHA(V) INTEGRINS [J].

FRIEDLANDER, M ;

BROOKS, PC ;

SHAFFER, RW ;

KINCAID, CM ;

VARNER, JA ;

CHERESH, DA .

SCIENCE, 1995, 270 (5241) :1500-1502

[7] SJA6017, a newly synthesized peptide aldehyde inhibitor of calpain: amelioration of cataract in cultured rat lenses [J].

Fukiage, C ;

Azuma, M ;

Nakamura, Y ;

Tamada, Y ;

Nakamura, M ;

Shearer, TR .

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1997, 1361 (03) :304-312

[8] TUMOR-GROWTH AND NEOVASCULARIZATION - EXPERIMENTAL MODEL USING RABBIT CORNEA [J].

GIMBRONE, MA ;

COTRAN, RS ;

LEAPMAN, SB ;

FOLKMAN, J .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1974, 52 (02) :413-427

[9]

HERBERT JM, 1988, INT J TISS REAC, V3, P133

[10]

Kenyon BM, 1996, INVEST OPHTH VIS SCI, V37, P1625

← 1 2 3 →